People With Diabetes and Caregivers Prefer Rescue Glucagon Treatment With a Wider Storage Temperature Range and a Nasal Administration, When Efficacy is Similar: A Discrete Choice Experiment in Spain.

Mitchell, Beth D; Rentz, Anne M; Kummer, Shannon; Yan, Yu; Heidenreich, Sebastian; Krucien, Nicolas; Artime, Esther; Osumili, Beatrice; Rubio, Miriam; Gelhorn, Heather L

Mitchell, Beth D; Rentz, Anne M; Kummer, Shannon; Yan, Yu; Heidenreich, Sebastian; Krucien, Nicolas; Artime, Esther; Osumili, Beatrice; Rubio, Miriam; Gelhorn, Heather L.

Affiliation

Mitchell BD; Eli Lilly and Company, Indianapolis, IN, USA.
Rentz AM; Evidera, Bethesda, MD, USA.
Kummer S; Evidera, Bethesda, MD, USA.
Yan Y; Eli Lilly and Company, Indianapolis, IN, USA.
Heidenreich S; Evidera, London, UK.
Krucien N; Evidera, London, UK.
Artime E; Eli Lilly and Company, Indianapolis, IN, USA.
Osumili B; Eli Lilly and Company, Indianapolis, IN, USA.
Rubio M; Eli Lilly and Company, Indianapolis, IN, USA.
Gelhorn HL; Evidera, Bethesda, MD, USA.

J Diabetes Sci Technol ; 17(6): 1623-1633, 2023 11.

Article in En | MEDLINE | ID: mdl-35533142

Subject(s)
Key words

diabetes; glucagon; nasal administration; patient preference

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Hypoglycemia Aspects: Patient_preference Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Diabetes Sci Technol Journal subject: ENDOCRINOLOGIA Year: 2023 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google